Gefitinib (a selective inhibitor of EGFR tyrosine kinase) ameliorated renal fibrosis and macrophage infiltration by inhibiting the EGFR-STAT3-HIPK2 axis in AKI [51]. This evidence concerns the gene STAT3 and acute kidney injury.